BioNTech SE
NASDAQ:BNTX
BioNTech SE
NASDAQ:BNTX
Price:
109.935
USD
-0.37%
Market Closed
Market Cap:
$26.4B
Balance Sheet
Balance Sheet Decomposition
BioNTech SE
BioNTech SE
Balance Sheet Decomposition is not available for
BioNTech SE
BioNTech SE
Balance Sheet
BioNTech SE
BioNTech SE
Currency: EUR
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
172
|
411
|
519
|
1 210
|
1 693
|
13 875
|
11 664
|
9 762
|
|
| Cash |
172
|
411
|
519
|
1 210
|
1 693
|
13 875
|
11 664
|
9 762
|
|
| Short-Term Investments |
0
|
0
|
2
|
137
|
382
|
189
|
4 885
|
7 022
|
|
| Total Receivables |
9
|
28
|
20
|
171
|
12 382
|
7 146
|
2 340
|
1 524
|
|
| Accounts Receivables |
5
|
19
|
12
|
165
|
12 382
|
7 146
|
2 161
|
1 474
|
|
| Other Receivables |
4
|
9
|
8
|
6
|
0
|
0
|
179
|
50
|
|
| Inventory |
4
|
6
|
12
|
64
|
503
|
440
|
358
|
283
|
|
| Other Current Assets |
5
|
3
|
7
|
85
|
113
|
272
|
281
|
213
|
|
| Total Current Assets |
190
|
449
|
560
|
1 667
|
15 072
|
21 922
|
19 527
|
18 804
|
|
| PP&E Net |
102
|
116
|
148
|
326
|
520
|
821
|
972
|
1 183
|
|
| PP&E Gross |
102
|
116
|
148
|
326
|
520
|
821
|
972
|
1 183
|
|
| Accumulated Depreciation |
28
|
37
|
49
|
58
|
74
|
116
|
212
|
318
|
|
| Intangible Assets |
83
|
88
|
86
|
110
|
145
|
159
|
804
|
790
|
|
| Goodwill |
1
|
1
|
3
|
54
|
58
|
61
|
363
|
381
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
21
|
80
|
1 176
|
1 254
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
162
|
14
|
236
|
165
|
108
|
|
| Other Assets |
1
|
1
|
3
|
54
|
58
|
61
|
363
|
381
|
|
| Total Assets |
375
N/A
|
653
+74%
|
798
+22%
|
2 319
+191%
|
15 831
+583%
|
23 279
+47%
|
23 006
-1%
|
22 530
-2%
|
|
| Liabilities | |||||||||
| Accounts Payable |
53
|
42
|
20
|
102
|
160
|
204
|
354
|
427
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
8
|
3
|
6
|
130
|
36
|
28
|
40
|
|
| Other Current Liabilities |
104
|
76
|
114
|
498
|
3 192
|
2 711
|
1 688
|
2 057
|
|
| Total Current Liabilities |
159
|
126
|
138
|
606
|
3 482
|
2 951
|
2 071
|
2 523
|
|
| Long-Term Debt |
0
|
6
|
69
|
231
|
172
|
176
|
191
|
215
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
67
|
6
|
40
|
42
|
|
| Minority Interest |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
264
|
254
|
97
|
109
|
217
|
91
|
459
|
338
|
|
| Total Liabilities |
424
N/A
|
387
-9%
|
304
-21%
|
947
+212%
|
3 937
+316%
|
3 224
-18%
|
2 760
-14%
|
3 119
+13%
|
|
| Equity | |||||||||
| Common Stock |
167
|
193
|
232
|
246
|
246
|
249
|
249
|
249
|
|
| Retained Earnings |
216
|
73
|
267
|
1 130
|
11 651
|
19 812
|
20 008
|
19 171
|
|
| Treasury Stock |
0
|
0
|
6
|
5
|
4
|
5
|
11
|
9
|
|
| Total Equity |
49
N/A
|
266
N/A
|
493
+85%
|
1 372
+178%
|
11 894
+767%
|
20 056
+69%
|
20 246
+1%
|
19 411
-4%
|
|
| Total Liabilities & Equity |
375
N/A
|
653
+74%
|
798
+22%
|
2 319
+191%
|
15 831
+583%
|
23 279
+47%
|
23 006
-1%
|
22 530
-2%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
226
|
226
|
227
|
242
|
243
|
243
|
238
|
240
|
|
Switch to:
Switch to:
See Also
Discover More
